ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
BIO key International Inc

BIO key International Inc (BKYI)

1.795
-0.025
(-1.37%)
Closed July 14 4:00PM
1.795
0.00
(0.00%)
After Hours: 5:11PM

BKYI Discussion

View Posts
wickw50 wickw50 6 days ago
Williamsburg, VA Advances Zero Trust Initiative for City Infrastructure and Data with BIO-key Identity-Bound Biometrics


WILLIAMSBURG, Va. and HOLMDEL, N.J., July 08, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software featuring passwordless, phoneless and token-less Identity-Bound Biometrics (IBB) authentication solutions, announces that the City of Williamsburg, VA has selected BIO-key’s PortalGuard IDaaS platform to enhance its security posture under a comprehensive Zero Trust initiative.

City governments like Williamsburg face numerous challenges related to authentication security, given their responsibility for protecting sensitive information and providing critical services to their constituents. Williamsburg’s senior IT leadership sought robust authentication mechanisms such as advanced multi-factor authentication (MFA) and biometrics to mitigate these threats. Williamsburg selected BIO-key’s solution over competitive offerings, enabling it to consolidate security vendors and implement a unified platform for secure access to systems and data across the municipality. PortalGuard IDaaS and its IBB capabilities will streamline access workflows for city users and deliver cost savings by securing desktop access with passwordless authentication.

The power of BIO-key’s identity bound biometrics (IBB) is in establishing trust and accountability rooted in a person's biometric identity. Biometrics provides assurance of a genuine presence as well as an audit trail with full transparency. IBB also eliminates a common authentication point of failure by removing physical devices (such as tokens or keys) as potential vulnerabilities, while PortalGuard provides the user with flexible authentication options to ensure security as well as usability.

"Government entities continue to be prime targets for cyber-attacks, including phishing, ransomware, and other forms of cybercrime, so ensuring data security is paramount as breaches can have severe legal, financial and reputational consequences,” said Mark Cochran, President of BIO-key’s PortalGuard division. “BIO-key has an extensive track record of collaboration with state, county, and local entities, built on our ongoing commitment to providing quick time-to-value security solutions and IBB to deliver passwordless authentication.”

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement

All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products, the commercial, reputational and regulatory risks to our business that may arise as a consequence the restatement of our financial statements, including any consequences of non-compliance with Securities and Exchange Commission (“SEC”) and Nasdaq periodic reporting requirements; our temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future; any disruption to our business that may occur on a longer-term basis should we be unable to remediate during fiscal year 2024 certain material weaknesses in our internal controls over financial reporting, and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
wickw50 wickw50 3 weeks ago
BIO-key Secures Los Angeles LGBT Center's IT Systems with Seamless Badge-Tap Authentication Solution


HOLMDEL, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software infrastructure featuring passwordless, phoneless and token-less Identity-Bound Biometrics (IBB) authentication solutions, today announces that Los Angeles LGBT Center with 17 locations and nearly 800 employees has selected its PortalGuard® platform for secure, streamlined desktop sign-in that meets regulatory and insurance compliance requirements. The most prominent LGBTQ+ organization in the world, the Center offers programs, services, and advocacy spanning four areas: Health, Social Services and Housing, Culture and Education, and Leadership.

The newly implemented system marks a significant advancement for the Center, offering a highly scalable solution that includes enterprise-grade identity and access management capabilities and an identity provider (IDP) engine. BIO-key’s state-of-the-art PortalGuard security solution provides a badge-tap authentication system that eliminates the need for traditional password entry, ensuring secure and efficient access to critical resources in the Center. Using Center-provided badges, end-users can now simply tap their badge on a workstation reader and enter a 4-digit PIN to automatically sign in to their daily applications. PortalGuard has enhanced security and significantly reduced IT support demands, allowing LA LGBT Center staff to focus more on patient care.

"The decision to partner with BIO-key was influenced by the Center's goal to find an IAM solution that would bolster security while improving workflow efficiencies – like, for example, nurses accessing exam rooms,” said Mark Cochran, President of BIO-key’s PortalGuard division. “Additionally, unlike other competitive products that require extensive Active Directory modifications, our PortalGuard solution seamlessly integrates smoothly with the Center’s current infrastructure, minimizing disruption and maximizing productivity. BIO-key’s collaboration with the Los Angeles LGBT Center exemplifies our commitment to providing healthcare organizations with robust security solutions that simplify end-user access and workflows.”

Please visit the BIO-key website to learn about PortalGuard, Identity-Bound Biometrics, and Passkey:YOU.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products, the commercial, reputational and regulatory risks to our business that may arise as a consequence the restatement of our financial statements, including any consequences of non-compliance with Securities and Exchange Commission (“SEC”) and Nasdaq periodic reporting requirements; our temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future; any disruption to our business that may occur on a longer-term basis should we be unable to remediate during fiscal year 2024 certain material weaknesses in our internal controls over financial reporting, and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors : @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
wickw50 wickw50 4 weeks ago
HOLMDEL, N.J., June 17, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its first quarter ended March 31, 2024 (Q1’24). Note, BIO-key’s results for the first three quarters of 2023 were restated at year-end and filed with the Company’s 2023 Form 10-K, and as a result Q1’23 comparisons in this release have been restated. BIO-key will host an investor call Tuesday, June 18th at 10:00am ET (details below).

Q1 Financial Highlights

Q1’24 revenues of $2.2M were in line with Q1’23 and increased 19.5% from Q4’23 revenues of $1.8M
Gross profit increased to $1.9M (86.3% gross margin) from $0.9M (40% gross margin) in Q1’23, reflecting the impact of a Q1’23 $0.5M hardware inventory reserve, as well as higher software license fees in Q1’23 due to higher royalty payments on third-party software solutions.
Operating expenses were reduced over $0.2M in Q1’24 versus Q1’23, reflecting ongoing cost management initiatives.
BIO-key reported a Q1’24 net loss of $0.5M compared to a net loss of $1.7M in Q1’23
Cash generated from operating activities improved to $0.3M in Q1’24 vs. a $1.9M cash used in Q1’23, principally reflecting the benefit of a $1.5M cash payment in Q1’24 for 2-year extension/expansion of biometric technology license with a long-term financial services customer.
Other Recent Software Deployments:

Fargo, ND and Junction City, KS Chose PortalGuard with Biometric Authentication
Bridgetown, Barbados Credit Union Selected PortalGuard with Biometrics for Shared Workstations
Commentary
BIO-key CEO, Mike DePasquale commented, “BIO-key delivered solid progress in Q1’24, achieving positive cash flow from operations in the period, on revenue of $2.2M, representing a 19.5% increase over Q4’23 and roughly flat with the year-ago period. The current-year period benefitted from the expanded deployment of BIO-key’s biometric client identification system used by a long-standing financial services client. We also further trimmed operating expenses during Q1’24, contributing to our improved bottom-line performance.

“We remain focused on driving revenue growth and progressing our business to profitability and positive cash flow over the next several quarters. We are encouraged by the traction building within our global Channel Alliance Partner program and with the larger-scale customer dialogues in which we are engaged through our in-house direct sales effort. We believe the cybersecurity landscape continues to provide a compelling backdrop for our company, as we expect it will generate increased demand for secure, zero-trust Identity and Access Management solutions that are the core of our offerings.

“Tailwinds that we expect to support our growth include a growing proportion of enterprises that are moving IT infrastructure to the cloud as well as increasingly stringent regulatory standards as well as cyber insurance underwriting requirements, much of which are now mandating multi-factor authentication or passwordless security solutions that BIO-key is well positioned to provide on a very competitive basis.

“We are also very bullish on the growth potential for passkey authentication this year and going forward. We entered this market with the recent launch of Passkey:YOU – BIO-key’s unique passwordless authentication solution that leverages our strength in biometric security to deliver secure passkeys without the use of phones or hardware tokens.

“We continue to pursue large enterprise opportunities through our direct sales channel, looking to build on recent successes in this area. We are also working to support our global channel partners in developing new customer opportunities to further build our end-user base. Our efforts have forged a growing base of high-margin annually recurring revenues (ARRs) and believe there is substantial potential to grow our ARR base moving forward. At the same time, we will continue to pursue cost reduction opportunities to accelerate our path to profitability and positive cash flow. We are also working to identify potential strategic opportunities to leverage our growing global base of customers to accelerate shareholder value creation. For these and other reasons, we believe BIO-key is well-positioned for the future.”

Financial Results
Q1’24 revenues of $2.2M were in line with similarly strong Q1’23 revenues. The current-year period was positively impacted by the expanded use of BIO-key’s biometric client identification system by a long-time financial services customer in South Africa. One large order from this customer in Q1’24 was the primary driver of a 23.6% increase in license fee revenues, offset by a decline in recurring and custom services and hardware revenue. Services revenue decreased due to the loss of one large service agreement and the absence of a large customer for Swivel Secure customizations and upgrades, which had occurred in Q1’23.

Gross profit grew over 100% to $1.9M in Q1’24 from $0.9M in Q1’23, reflecting the impact of $0.5M hardware reserve in Q1’23, as well as higher software license fee costs in Q1’23 related to royalty payments resulting from higher sales of our third-party Swivel Secure offerings. As a result, gross profit margin improved to 86% in Q1’24 vs. 40% in Q1’23, which includes a hardware reserve expense. Q1’24 gross margin also increased due to a revenue mix that included more high-margin license fee revenue.

Total operating expenses were reduced by approximately $0.2M or 9%, to $2.4M in Q1’24 from $2.6M in Q1’23, due to lower selling, general and administrative costs (SG&A) and lower research, development and engineering expenses (RD&E). SG&A decreased $148,759 (8%) to $1.8M in Q1’24, due to reductions in administration, sales personnel costs and marketing show expenses, including lower lease expense for our NJ headquarters versus Q1’23, partially offset by higher audit and reporting expenses. In Q3 of 2023, we were able to downsize our corporate headquarters, as many of our team now work remotely, which benefitted Q1’24 vs. Q1’23. RD&E also declined by $82,638 (12%) to $607,521, due to reductions in personnel, related benefits and outside services expenses.

Reflecting revenue strength and lower operating costs, BIO-key trimmed its net loss by 70% to $510,285, or $0.32 per share, in Q1’24 from $1.7M, or $3.51 per share, in Q1’23.

Balance Sheet
At March 31, 2024, BIO-key had current assets of approximately $2.3M, including $690,449 of cash and cash equivalents, $710,026 of net accounts receivable and due from factor, and $440,194 of inventory.

Conference Call Details
Date / Time: Tuesday, June 18th at 10 a.m. ET
Call Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int’l
Live Webcast / Replay: Webcast & Replay Link – Available for 3 months.
Audio Replay: 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 1988012

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products, the commercial, reputational and regulatory risks to our business that may arise as a consequence the restatement of our financial statements, including any consequences of non-compliance with Securities and Exchange Commission (“SEC”) and Nasdaq periodic reporting requirements; our temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future; any disruption to our business that may occur on a longer-term basis should we be unable to remediate during fiscal year 2024 certain material weaknesses in our internal controls over financial reporting, and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800



BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)


Three Months Ended
March 31,
2024 2023
Revenues
Services $ 213,122 $ 532,522
License fees 1,950,434 1,578,556
Hardware 17,647 72,689
Total revenues 2,181,203 2,183,767
Costs and other expenses
Cost of services 138,849 154,801
Cost of license fees 148,221 620,881
Cost of hardware 12,573 44,592
Cost of hardware - reserve - 500,000
Total costs and other expenses 299,643 1,320,274
Gross profit 1,881,560 863,493

Operating Expenses
Selling, general and administrative 1,782,973 1,931,732
Research, development and engineering 607,521 690,159
Total Operating Expenses 2,390,494 2,621,891
Operating loss (508,934 ) (1,758,398 )
Other income (expense)
Interest income 5 4
Loss on foreign currency transactions - (15,000 )
Change in fair value of convertible note - 141,991
Interest expense (1,356 ) (56,919 )
Total other income (expense), net (1,351 ) 70,076

Loss before provision for income tax (510,285 ) (1,688,322 )

Provision for (income tax) tax benefit - -

Net loss $ (510,285 ) $ (1,688,322 )

Comprehensive loss:
Net loss $ (510,285 ) $ (1,688,322 )
Other comprehensive income (loss) – Foreign currency translation adjustment (62,275 ) 72,146
Comprehensive loss $ (572,560 ) $ (1,616,176 )

Basic and Diluted Loss per Common Share $ (0.32 ) $ (3.51 )

Weighted Average Common Shares Outstanding:
Basic and diluted 1,615,323 480,833
All BIO-key shares issued and outstanding for all periods reflect BIO-key’s 1-for-18 reverse stock split, which was effective December 21, 2023.



BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS


March 31, December 31,
2024 2023
(Unaudited)
ASSETS
Cash and cash equivalents $ 690,449 $ 511,400
Accounts receivable, net 701,776 1,201,526
Due from factor 8,250 99,320
Inventory 440,194 445,740
Prepaid expenses and other 427,685 364,171
Total current assets 2,268,354 2,622,157
Equipment and leasehold improvements, net 198,238 220,177
Capitalized contract costs, net 349,145 229,806
Operating lease right-of-use assets 23,220 36,905
Intangible assets, net 1,329,985 1,407,990
Total non-current assets 1,900,588 1,894,878
TOTAL ASSETS $ 4,168,942 $ 4,517,035

LIABILITIES
Accounts payable $ 1,212,071 $ 1,316,014
Accrued liabilities 1,189,520 1,305,848
Government loan – BBVA Bank, current portion 135,835 138,730
Deferred revenue, current 755,405 414,968
Operating lease liabilities, current portion 23,797 37,829
Total current liabilities 3,316,628 3,213,389
Deferred revenue, long term 143,727 28,296
Deferred tax liability 22,998 22,998
Government loan – BBVA Bank – net of current portion 149,861 188,787
Total non-current liabilities 316,586 240,081
TOTAL LIABILITIES 3,633,214 3,453,470

Commitments and Contingencies

STOCKHOLDERS’ EQUITY

Common stock — authorized, 170,000,000 shares; issued and outstanding; 1,814,414 and 1,032,777 of $.0001 par value at March 31, 2024 and December 31, 2023, respectively 181 103
Additional paid-in capital 126,092,496 126,047,851
Accumulated other comprehensive loss (39,454 ) 22,821
Accumulated deficit (125,517,495 ) (125,007,210 )
TOTAL STOCKHOLDERS’ EQUITY 535,728 1,063,565
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 4,168,942 $ 4,517,035
All BIO-key shares issued and outstanding for all periods reflect BIO-key’s 1-for-18 reverse stock split, which was effective December 21, 2023.



BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)


Three Months Ended
March 31,
2024 2023

CASH FLOW FROM OPERATING ACTIVITIES:
Net loss $ (510,285 ) $ (1,688,322 )
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation 23,808 13,242
Amortization of intangible assets 78,005 81,237
Change in fair value of convertible note - (141,991 )
Amortization of capitalized contract costs 38,665 37,529
Reserve for inventory - 500,000
Operating leases right-of-use assets 13,686 66,132
Share and warrant-based compensation for employees and consultants 47,790 59,373
Stock based directors’ fees 9,003 12,002
Bad debts 100,000 -
Change in assets and liabilities:
Accounts receivable 399,749 (898,881 )
Due from factor 91,070 (33,000 )
Capitalized contract costs (158,005 ) (8,739 )
Inventory 5,545 6,554
Prepaid expenses and other (63,513 ) 2,219
Accounts payable (116,012 ) 88,040
Accrued liabilities (104,257 ) (135,417 )
Deferred revenue 455,868 178,755
Operating lease liabilities (14,033 ) (67,544 )
Net cash provided by (used in) operating activities 297,084 (1,928,811 )
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures (1,869 ) -
Net cash used in investing activities (1,869 ) -
CASH FLOW FROM FINANCING ACTIVITIES:
Deferred offering costs (13,470 ) -
Proceeds for exercise of warrants 1,400 -
Repayment of government loan (41,821 ) (34,289 )
Net cash used in financing activities (53,891 ) (34,289 )

Effect of exchange rate changes (62,275 ) 49,913

NET DECREASE IN CASH AND CASH EQUIVALENTS 179,049 (1,913,187 )
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 511,400 2,635,522
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 690,449 $ 722,335
All BIO-key shares issued and outstanding for all periods reflect BIO-key’s 1-for-18 reverse stock split, which was effective December 21, 2023.
👍️0
wickw50 wickw50 1 month ago
BIO-key Introduces Passkey:YOU, a Phish-resistant, Phoneless and Tokenless Biometric FIDO Passkey Authentication Solution

Convenient, Lower-cost FIDO Passkey Authentication Provides a Superior User Experience powered by BIO-key's Identity-Bound Biometrics


HOLMDEL, N.J., June 14, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software infrastructure featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced the launch of a unique biometric FIDO passkey authentication solution targeting underserved workplace scenarios in manufacturing, retail, healthcare, call center and Sensitive Compartmentalized Information Facilities (SCIFs): Passkey:YOU.

Eliminating passwords and implementing multi-factor authentication (MFA) is a goal of nearly every security-conscious enterprise, but mainstream IAM platforms offer only limited “what you have” authentication options based on phone apps and FIDO tokens. These options are ill-suited for many workplace scenarios that prohibit the use of phones or personal devices, leading to challenges in implementing passwordless or MFA without using phones. The current industry-standard phone-less authentication solution is FIDO hardware tokens, requiring enterprises to purchase two or more FIDO hardware tokens for every user, ranging in cost from $25-$70 each, not to mention replacing user tokens when lost. The leading FIDO token manufacturer states that 25% annual token replacement is typical. The economics of procuring hardware tokens for tens of thousands of roving users to access an often much smaller set of shared workstations and devices just doesn’t make business sense.

Passkey:YOU avoids the high cost of buying FIDO hardware tokens for every user, turning the unfavorable economics of FIDO hardware tokens on its head by placing authentication hardware at device access points, not in every user’s pocket. Passkey:YOU leverages the managed hosted FIDO-certified passkey capabilities of BIO-key’s partner IDmelon’s managed passkey solution to replace per-user tokens and phones as device authenticators with a simple touch of a shared USB fingerprint scanner or the tap of a standard door access badge to a shared USB NFC scanner connected to any Windows workstation to unlock a managed Passkey for the user, authenticating the user without a phone or a FIDO hardware token needed.

In its biometric mode, Passkey:YOU is powered by BIO-key’s renowned Identity-Bound Biometrics, allowing an unlimited number of users to be their own phish-proof credential, eliminating the need for them to carry any device or token to authenticate and get work done. BIO-key’s biometric platform includes privacy law-compliant workflows and provides user controlled privacy dashboards, ensuring that enterprises can use biometrics with confidence that they will comply with privacy laws in every jurisdiction. Passkey:YOU’s phoneless and tokenless authentication is a user-centric, more cost-effective approach that is ideally suited for scenarios where users operate without phones, such as manufacturing shop floor, retail, call center, higher education, and healthcare. In addition to biometric access, Passkey:YOU also supports standard proximity door access cards as authenticators for appropriate security applications.

By eliminating the requirement for a phone or FIDO hardware token to strongly authenticate users, Passkey:YOU fills gaps in mainstream authentication, and is a drop-in, zero-configuration replacement for any application or identity provider that currently accepts FIDO hardware tokens or phone-based passkeys. Passkey:YOU can be deployed as a hosted or on-premise deployment, and provides security teams immediate visibility into user access patterns to third-party applications that traditional FIDO security keys do not. Passkey:YOU facilitates passwordless workflows and integrates seamlessly into zero-trust frameworks and existing Identity and Access Management (IAM) platform identity providers such as Microsoft Entra, Okta, Ping and Duo. With Passkey:YOU, users can effortlessly present a biometric-secured FIDO passkey, serving as a drop-in replacement for existing FIDO and WebAuthn passkeys or hardware tokens, ensuring secure and convenient authentication for every user.

“FIDO Passkeys are quickly becoming the dominant means to combat phishing and eliminate passwords for enterprise users,” said Jim Sullivan, SVP of Strategy and Chief Legal Officer at BIO-key. “Unfortunately, the mainstream ‘what-you-have’ approaches center on phone apps and hardware key-based passkeys, which don’t work in many workforce user scenarios. Our customers asked us to solve the passwordless and multi-factor authentication challenge arising among the largest segments of their digitally enabled workforces – what-you-have authentication approaches are inefficient, allow account sharing, and are too expensive. With our partner IDmelon, we developed a BIO-key-secured passkey authentication solution that makes using passkeys to eliminate passwords effortless while instantly identifying users with certainty. This authentication product should be a valuable tool for hundreds of thousands of global enterprises that struggle to deliver passwordless and strong authentication all users with their existing IAM platform choice.”

BIO-key's Passkey:YOU boasts unique technology and efficiency differentiations from existing passkey approaches:

Cost & Efficiency: Passkey:YOU cuts lifecycle costs by 50 – 70% compared to FIDO hardware tokens while exceeding strong authentication requirements of cyber insurers to avoid increased premiums or dropped coverage.
Flexibility and Familiarity: Passkey:YOU can be easily integrated into existing authentication processes for identity providers, applications, and infrastructure, because it presents to FIDO-compliant relying parties as a standard FIDO authenticator. There’s no need to rip and replace existing identity providers. Passkey:YOU has a minimal contact surface with existing systems because it leverages FIDO-certified workflows. One-time enrollment enables access across multiple devices and locations, without configuration of any relying party necessary.
Security: Passkey:YOU is powered by BIO-key's Identity-Bound Biometrics, which supports over 30 different fingerprint scanners interchangeably, utilizes centrally managed and encrypted NIST-certified biometrics, secured by patented 1024-bit encryption to defeat man-in-the-middle and replay attacks.
Biometric Privacy Law Compliance: BIO-key’s enrollment and operational workflows were designed to ensure compliance with global biometric privacy laws, ensuring that enterprises can yield the benefits of biometrics with confidence that compliance and privacy are integral to the platform.
Please visit the BIO-key website to learn more about Passkey:YOU and Identity-Bound Biometrics.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement

All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products, the commercial, reputational and regulatory risks to our business that may arise as a consequence the restatement of our financial statements, including any consequences of non-compliance with Securities and Exchange Commission (“SEC”) and Nasdaq periodic reporting requirements; our temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future; any disruption to our business that may occur on a longer-term basis should we be unable to remediate during fiscal year 2024 certain material weaknesses in our internal controls over financial reporting, and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key
Facebook – Corporate:
LinkedIn – Corporate:
Twitter – Corporate:
Twitter – Investors:
StockTwits:
https://www.facebook.com/BIOkeyInternational/
https://www.linkedin.com/company/bio-key-international
@BIOkeyIntl
@BIO_keyIR
BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
wickw50 wickw50 1 month ago
HOLMDEL, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q1 2024 investor call Tuesday, June 18th at 10 a.m. ET. Results will be released prior to the call. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference and Q&A session.

Conference Call Details
Date / Time: Tuesday, June 18th at 10 a.m. ET
Call Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int’l
Live Webcast / Replay: Webcast & Replay Link – Available for 3 months.
Audio Replay: 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 1988012

BIO-key at a Glance
Recent Price $1.76 2023 Revenue $7.8M
Shares Out.* 1.9M 2023 Revenue Growth +10.5%
Market Cap $3.3M Price/2023 Sales 0.4X

* Common stock and common stock equivalents outstanding.

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over 40 million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
👍️0
wickw50 wickw50 1 month ago
June 4, 2024 – BIO-key is working to refile a series of financial statements to correct errors made while incorporating the finances of a recently-acquired subsidiary. In the meantime, the company has received a notice of non-compliance from Nasdaq for failing to file its Form 10-Q for its fourth quarter of fiscal 2023, which ended March 31, 2024.
A new Form 12b-25 filing with the Nasdaq shows BIO-key “made certain errors in the manner in which it recognized revenue generated” by Swivel Secure Europe, which it acquired in 2022 to extend the market reach of its biometric multi-factor authentication (MFA).
👍️0
wickw50 wickw50 1 month ago
Identity and Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9:00am ET


NEW YORK and HOLMDEL, N.J., May 31, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions will participate in the 2024 Virtual Tech Conference Series, presented by Maxim Group LLC and hosted by M-Vest June 4th-5th. BIO-key’s CEO Mike DePasquale will join a Fireside chat with Maxim on Tuesday, June 4th from 9:00 to 9:30 a.m. ET.

The conference, including panel discussions and fireside chats will be hosted live on M-Vest. Visit: https://m-vest.com/events/tmt-06042024 to sign-in or sign up to become an M-Vest member and access the event. Investors can submit questions to the moderator throughout the panel, as well as request management meetings.

The continuous evolution of technology is paving the way for innovations across all industries. In this conference Maxim will explore how emerging growth companies are leveraging new technologies such as Artificial Intelligence (AI) to position themselves for the future. Senior analysts will facilitate engaging dialogues with CEOs and key management of companies who have their attention on technology and how it will impact and grow their business.

Maxim Group LLC is a leading full-service investment bank, securities and wealth management firm headquartered in New York. Maxim provides a full array of financial services to a diverse range of corporate clients, institutional investors and high net worth individuals.

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
👍️0
wickw50 wickw50 2 months ago
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq


WALL, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on May 22, 2024, it received a letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“SEC”), due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Form 10-Q”). The Notification Letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.

The Company filed a Notification of Late Filing on Form 12b-25 on May 16, 2024, indicating that the filing of the Form 10-Q would be delayed because it was unable to timely file the Form 10-Q without unreasonable effort and expense. As previously announced, the Company is in the process of restating its consolidated financial statements for the three months ended March 31, 2023, the three and six months ended June 30, 2023, and the three and nine months ended September 30, 2023 which has delayed the compilation, presentation and review of certain financial and other disclosures required to be included in the Form 10-Q.

The Notification Letter stated that the Company remains delinquent in filing its Form 10-K for the period ended December 31, 2023 (the “Form 10-K”) and has until June 17, 2024 to submit a plan to regain compliance with respect to these delinquent reports. If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the filing due date of the 10-K, or until October 14, 2024, to regain compliance. The Company intends to file the Form 10-Q and the Form 10-K with the SEC as soon as practicable and regain compliance with Nasdaq’s continued listing requirements.

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement

All statements contained in this press release other than statements of historical facts are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbor” provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; the duration and extent of continued hostilities in Ukraine and its impact on our European customers; delays in the development of products, the nature and estimated amount of adjustments to our previously issued financial statements covering the quarterly periods in 2023, as well as the nature and estimated adjustments that may be required from our preliminary estimates of results for 2023 and first quarter of 2024, as the final adjustments may vary from the amounts estimated in our prior SEC Reports, which variance may be material; the commercial, reputational and regulatory risks to our business that may arise as a consequence of our need to restate our financial statements, including any consequences of non-compliance with Securities and Exchange Commission (“SEC”) and Nasdaq periodic reporting requirements; our temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future; any disruption to our business that may occur on a longer-term basis should we be unable to remediate during fiscal year 2024 certain material weaknesses in our internal controls over financial reporting, and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key:

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
👍️0
wickw50 wickw50 2 months ago
BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week


HOLMDEL, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, today announced that it currently expects to file its audited 2023 results with the SEC on Form 10-K next week. BIO-key also expects to report its Q1 2024 results and hold an investor call by the end of next week. The Company will announce the timing and details of its Q1 2024 investor call once they are confirmed.

On April 23, 2024, BIO-key engaged Bush & Associates CPA as its independent registered public accounting firm.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties, including, but are not limited to, those factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission, that may cause actual results to differ materially from those included within or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
wickw50 wickw50 2 months ago
BIO-key Wins Coveted Global InfoSec Award for Multi-factor Authentication During RSA Conference 2024

“Hot Company Multi-Factor Authentication” Award Winner in 12th Annual Global InfoSec Awards at #RSAC 2024


HOLMDEL, N.J. and SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less FIDO and Passkey authentication solutions through its unique Identity Bound Biometrics (IBB) capabilities, is proud to announce it has won the Hot Company Multi-Factor Authentication award from Cyber Defense Magazine (CDM), the industry’s leading electronic information security magazine.

Hot Company Multi-Factor Authentication

BIO-key’s award-winning unified IAM platform PortalGuard® allows enterprises to offer flexible options for authentication, including all of the traditional phone and token-based FIDO approaches, but adding the higher ceiling of IBB – a biometric-secured, token-less, phone-less option for everyday sign in and for self-service account recovery using biometric-secured identities for maximum identity certainty.

“We’re thrilled to receive one of the most prestigious cybersecurity awards in the world from Cyber Defense Magazine, during their 12th anniversary as an independent cybersecurity news and information provider. We knew the competition would be tough and with top judges who are leading infosec experts from around the globe, we couldn’t be more pleased,” said Michael DePasquale, CEO of BIO-key International. “We are honored to be a member of this exclusive group of winners,” located here: http://www.cyberdefenseawards.com/

“We scoured the globe looking for cybersecurity innovators that could make a huge difference and potentially help turn the tide against the exponential growth in cyber-crime. BIO-key International is absolutely worthy of this coveted award and consideration for deployment in your environment,” said Yan Ross, Global Editor of Cyber Defense Magazine.

Please join us at the #RSAC RSA Conference 2024, https://www.rsaconference.com/usa today, as we share our red-carpet experience and proudly display our trophy online at our website, our blog and our social media channels.

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

About CDM InfoSec Awards
This is Cyber Defense Magazine’s twelfth year of honoring InfoSec innovators from around the Globe. Our submission requirements are for any startup, early stage, later stage, or public companies in the Information Security (Infosec) space who believe they have a unique and compelling value proposition for their product or service. Learn more at www.cyberdefenseawards.com

About the Judging
The judges are CISSP, FMDHS, CEH, certified security professionals who voted based on their independent review of the company submitted materials on the website of each submission including but not limited to data sheets, white papers, product literature and other market variables. CDM has a flexible philosophy to find more innovative players with new and unique technologies, than the one with the most customers or money in the bank. CDM is always asking “What’s Next?” so we are looking for best of breed, next generation InfoSec solutions.

About Cyber Defense Magazine

Cyber Defense Magazine is the premier source of cyber security news and information for InfoSec professions in business and government. We are managed and published by and for ethical, honest, passionate information security professionals. Our mission is to share cutting-edge knowledge, real-world stories and awards on the best ideas, products, and services in the information technology industry. We deliver electronic magazines every month online for free, and special editions exclusively for the RSA Conferences. CDM is a proud member of the Cyber Defense Media Group. Learn more about us at https://www.cyberdefensemagazine.com and visit https://www.cyberdefensetv.com and https://www.cyberdefenseradio.com to see and hear some of the most informative interviews of many of these winning company executives. Join a webinar at https://www.cyberdefensewebinars.com and realize that infosec knowledge is power.

Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
wickw50 wickw50 3 months ago
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq


HOLMDEL, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on April 17, 2024, it received a letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“SEC”). The Notification letter is due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”). The Notification Letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.

The Company filed a Notification of Late Filing on Form 12b-25 on April 2, 2024, indicating that the filing of the Form 10-K would be delayed because the compilation, presentation and review of certain financial and other disclosures required to be included in the Form 10-K could not be completed within the prescribed time period without unreasonable effort and expense to the Company.

The Notification Letter stated that, under Nasdaq rules, the Company has 60 calendar days to submit a plan to regain compliance with Nasdaq’s continued listing requirements. If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the filing’s due date, or until October 14, 2024, to regain compliance. The Company intends to file the Form 10-K with the SEC as soon as practicable and regain compliance with Nasdaq’s continued listing requirements.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; the duration and extent of continued hostilities in Ukraine and its impact on our European customers; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key:

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
👍️0
wickw50 wickw50 3 months ago
Switzerland’s Canton of Ticino Implements BIO-key’s Multi-Factor Authentication Solution in its Information Systems Center


TICINO, Switzerland and HOLMDEL, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc.® (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced that Switzerland’s Canton of Ticino (Ticino) has partnered with Asecus AG to implement BIO-key’s AuthControl Sentry login solution. In a significant enhancement to its digital security, Ticino’s Information Systems Center (TISC) has integrated AuthControl’s advanced protection for Office365 login across their network. Ticino is the southernmost of Switzerland’s 26 cantons (member states) and the sole canton where Italian is the only official language.

The AuthControl Sentry implementation is a critical component of TISC’s strategy to safeguard its digital assets and communications, especially considering the widespread use of Office365 for day-to-day operations. The collaboration with Asecus underscores the Ticino’s commitment to utilizing top-tier security solutions to protect against potential cyber threats. The partnership not only enhances the security of TISC’s Office365 logins but also strengthens the overall integrity of its digital communications.

Alex Rocha, Managing Director of BIO-key Europe, commented, “Canton Ticino’s proactive approach to working with Asecus and BIO-key to secure their Office365 logins is a best practices model for maintaining a robust and resilient digital environment. In today’s interconnected world, it is vital for government entities to ensure the highest level of security for their communication tools. We at BIO-key Europe applaud their commitment to cybersecurity and are pleased to see our solutions contributing to such important initiatives.”

Asecus AG (https://www.asecus.ch/)
Cybersecurity Integrator and managed service provider Asecus has been successfully protecting customers against cyberattacks since 1997. Long-standing customers include both small and medium-sized entities and international corporations across various industries. Asecus provides first-class security consulting, security operations/managed services and support, as well as a broad portfolio of leading products. The Asecus team also brings extensive security expertise and engineering know-how to on-premises, cloud and hybrid environments.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts

William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
wickw50 wickw50 3 months ago
Profitability… that’s an elusive term when it comes to BIO-key… but the Mickey D club continues in Jersey…
👍️0
wickw50 wickw50 3 months ago
Identity and Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M; Investor Call Tomorrow at 10am ET


HOLMDEL, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced preliminary results for its fourth quarter (Q4’23) and year ended December 31, 2023 (2023). The independent audit of BIO-key’s 2023 financial statements has not yet been completed and, therefore, the figures included herein are subject to change. BIO-key will host an investor call tomorrow at 10:00am ET (details below).

Preliminary Results Highlights:

2023 revenue rose $2M (29%) to $9.1M
2023 SG&A trimmed by $2.1M (22%)
Net cash used in operating activities was reduced by $2.5M in 2023
Q4’23 & 2023 cost of hardware reflects $2.8M reserve against slow moving inventory for Africa
$1.5M cash payment received in Q1’24 for 2-year extension/expansion of biometric technology license
CEO Commentary
BIO-key CEO, Mike DePasquale commented, “BIO-key made solid progress on our path to profitability in 2023, driven by 29% revenue growth and cost cutting initiatives that trimmed SG&A expense by $2.1M, largely in the second half of the year. We look to build on this record in 2024, focusing on top-line growth opportunities balanced with further efforts to reduce costs. We believe our growing global distribution and customer base puts us in a strong position to reach profitability over the next several quarters.

“Looking forward, we expect increased deployment of enhanced IAM solutions as enterprises transition to the cloud and respond to a growing array of security incidents that highlight potential cybersecurity vulnerabilities. This trend is further supported by regulatory requirements and increasingly stringent Cyber Insurance underwriting standards that mandate enhanced multi-factor authentication and/or passwordless security solutions that are at the core of our offerings.

“As passwordless authentication gains traction, our solutions are well positioned to provide organizations an integrated approach to managing and securing all of their identities with technologies they already use, while also supporting their future needs with a cost-effective platform. We also expect that passkey authentication, which has been embraced by Google, Apple, Amazon and Microsoft, will continue to expand its penetration in 2024. To capitalize on this opportunity, BIO-key will soon launch, Passkey:YOU, a unique passwordless authentication solution that does not require the use of phones or hardware tokens, with planned enhancements expected later in the year.

Outlook
“The current climate of broad enterprise adoption of MFA to replace passwords presents opportunities for us to leverage our unique differentiators and exploit gaps in existing IAM approaches. Gaps include challenges of authenticating users that ‘rove’ among workstations and preventing unauthorized account sharing and delegation.

“Today BIO-key has more than 600 customers globally. Our business is predominately SaaS or subscription based, and most of our new business is sold through channel partners. We remain focused on an asset light go-to-market plan that leverages more than 150 Channel Alliance Partners, along with our targeted internal sale team. Together, we believe these channels position BIO-key for meaningful top- and bottom-line improvement in 2024, building on our base of annually recurring services and license fee revenues (ARRs) with a blended gross margin of approximately 65%.

“We will also continue to pursue cost reduction initiatives in 2024, to help accelerate our path to positive cash flow and profitability. Our Q4’23 bottom line included a $2.8M non-cash reserve on slow moving hardware inventory purchased for our Africa initiatives. We continue to explore opportunities to convert this inventory into cash. Importantly, during the first quarter of 2024 we enhanced our financial position with the execution of a $1.5M, 2-year license extension for a long-time customer and receipt the full license payment. We also continue to pursue large enterprise opportunities through our direct sales channel. For these and other reasons, we are particularly excited about BIO-key’s outlook for 2024.”

Preliminary Financial Results
Please note that the audit of our 2023 financial statements has not been completed by our independent registered public accounting firm as of the date of this press release and are, therefore, subject to change.

2023 revenues increased 29% to $9.1M from $7.0M in 2022, driven by increases in license fees (of $1.1M), hardware sales (of $0.5M); and services revenue (of $0.4M). Service revenue benefitted from custom services for new customer installations, Swivel Secure service fees, and conversions from on-premises deployments of PortalGuard to our PortalGuard IDaaS cloud platform. Hardware revenue benefitted from fourth quarter sales to an international defense agency in 2023. Likewise, Q4’23 revenue grew 26% over Q4’22, also driven by the aforementioned hardware sales to an international defense agency.

The Company took a $2.8M reserve on inventory due to slow moving inventory purchased for large projects in Nigeria in Q4’23. This reserve was included in cost of hardware, which caused a decline in gross profit to $3.3M in 2023, from $4.6M in 2022 and a decline in gross margin to 36.5% in 2023 from 65.2% in 2022. BIO-key continues to explore opportunities to sell the product, including other markets, to convert inventories to cash.

In terms of operating expenses, Selling, general and administrative costs were $7.3M in 2023, representing a 22% decrease from 2022. The decrease included lower sales and marketing expenses, including personnel and related benefits and outside services expenses. Research, development and engineering expenses also declined by $0.9M or 26% to $2.4M, due to reductions in personnel, related benefits and outside services expenses.

On a preliminary basis, reflecting higher revenue and lower operating costs, BIO-key significantly trimmed its 2023 net loss 48% to $(6.2M), or $(11.45) per share, from $(12.2M), or $(27.26) per share, in 2022, even after including the $2.8 million reserve on inventory. Likewise, in Q4’23 BIO-key reduced its net loss more than 40% to $(4.1M), or $(5.54) per share, from $(6.7M), or $(14.58) per share in 2023.

Preliminary Balance Sheet
At December 31, 2023, BIO-key had current assets of $5.3M, including $0.5M of cash and cash equivalents, $3.2M of accounts receivable and amounts due from factor, and $1.2M of inventory.

Conference Call Details

Date / Time: Tuesday, April 2nd at 10 a.m. ET
Call Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int’l
Live Webcast / Replay: Webcast & Replay Link – Available for 3 months.
Audio Replay: 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 6114035

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800

👍️0
wickw50 wickw50 4 months ago
HOLMDEL, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q4 2023 investor call Tuesday, April 2nd at 10 a.m. ET. Results will be released after the market close on Monday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the call and Q&A session.

Conference Call Details

Date / Time: Tuesday, April 2nd at 10 a.m. ET
Call Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int’l
Live Webcast / Replay: Webcast & Replay Link – Available for 3 months.
Audio Replay: 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 6114035

BIO-key at a Glance

Recent Price $2.00 TTM Revenue $8.6M
Shares Out.* 1.9M TTM Revenue Growth +39%
Market Cap $3.9M Price/TTM Revenue 0.45X
* Common stock and common stock equivalents outstanding.

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over 38 million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Engage with BIO-key

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts

William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
👍️0
wickw50 wickw50 4 months ago
BIO-key International, Inc. (NASDAQ:BKYI) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.36 and traded as low as $1.80. BIO-key International shares last traded at $1.90, with a volume of 39,816 shares traded.

BIO-key International Trading Down 5.9 %

The company has a current ratio of 1.30, a quick ratio of 0.59 and a debt-to-equity ratio of 0.07. The stock has a fifty day simple moving average of $1.98 and a 200 day simple moving average of $4.36.
👍️0
wickw50 wickw50 4 months ago
DUBAI, United Arab Emirates, March 11, 2024 (GLOBE NEWSWIRE) -- Humanity International Investments announces significant milestones in its innovative Humanity Protocol initiative. Over 40,000 NFTs have been claimed to date, showcasing the project making remarkable strides in digital identity and blockchain technology integration.

Humanity International Investments, under the Chairmanship of His Highness, Sheikh Marwan bin Mohamed bin Rashid Al Maktoum, launched a blockchain-based economic empowerment initiative, the Humanity Protocol, and strategically partnered with BIO-key (Nasdaq: BKYI), a leader in Identity and Access Management solutions including biometric palm scan authentication.

This collaboration will enable individuals, particularly in Africa, to authenticate their identities through a palm scan to securely claim their digital footprint through a Non-Fungible Token (NFT). The innovative approach not only enhances security and privacy in digital transactions but empowers individuals by providing them with a verified and immutable digital identity, marking a significant step forward in the integration of biometric technology with blockchain for identity verification. To date, the partnership has already garnered approximately 15,000 palm scans with plans to verify each of the current registered users.

"This milestone demonstrates our commitment to revolutionizing digital identity in Africa and beyond, made possible by our partnership with BIO-key, a leading biometric technology provider," said Aly Ramji, General Partner of Humanity International Investments.

The initiative has expanded to include a groundbreaking Community Staking program, engineered to function as a comprehensive ecosystem where Non-Fungible Tokens (NFTs) represent the identity of participants. Each NFT assigns a unique digital identity to each user but also facilitates a direct and transparent method for distributing economic returns.

With over 40,000 unique registered users across 94 countries, with a significant footprint in Nigeria, Kenya, and Vietnam, the Humanity Protocol demonstrates a sustainable model where community stakers back each participant. This backing is not just financial; it's a vote of confidence in the individuals' ability to contribute to and thrive within the digital economy.

"This innovative program is designed to provide financial benefits to participants, fostering a robust and financially inclusive community to those at the bottom of the pyramid across Africa and Asia", said Ramji.

The Humanity Protocol is pioneering a digital identity revolution, leveraging the potential of Africa's young and rapidly urbanizing population to ensure broader access to the decentralized digital economy. The community staking program is Humanity International Investment's commitment to inclusivity and security in the digital space.

For further inquiries with Humanity International Investment, please contact:
Communications@humanityinvestments.co

About Humanity International Investments (www.humanityinvestments.co)
Humanity International Investments is a Dubai-based social impact fund dedicated to fostering financial inclusion across Africa. With an expansive network spanning the continent, the organization is committed to bridging the identity gap for the unbanked and the ultra-poor. By collaborating with innovative technology partners, the Humanity Protocol seeks to provide verifiable identities, enabling countless Africans to access financial services, credit, and opportunities for wealth creation. Their vision is not just about creating identities but about empowering individuals to change their futures and have a voice in the global digital community.

For further inquiries with Bio-Key International, please contact:
732.359.1100
info@bio-key.com

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-eight million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Media Contact Full Name: Jumal Lewis
Media Contact Company: Humanity International Investments
Media Contact Phone Number: 1 (917) 833-1830
Media Contact Website: https://humanityinvestments.co/
Media Contact Email: communications@humanityinvestments.co

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6cee45fb-9e83-405f-ba12-87270dc12bee
👍️0
wickw50 wickw50 4 months ago
WALL, N.J., May 20, 2022 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) and large-scale identity solutions, will participate in the H.C. Wainwright Global Investment Conference 2022. The company’s presentation will be available on demand beginning Tuesday, May 24th at 7am ET. BIO-key’s CEO Mike DePasquale will be available for virtual investor meetings on Wednesday, May 25th and Thursday, May 26th.
👍️0
kennedytrading kennedytrading 5 months ago
Yep. Stock is manipulated. Time to sell before it drops
👍️0
wickw50 wickw50 5 months ago
Awl416, Much better! eom
👍️0
Awl416 Awl416 5 months ago
BIO-key Receives $1.5M Pre-Paid, Two-Year Software Subscription Order for its Biometric Identification Platform
👍️0
wickw50 wickw50 5 months ago
BIO-Key International CEO Michael Depasquale joined Steve Darling from Proactive to announce several significant contract wins for the company which specializes in advanced security and identity solutions.

De Pasquale highlighted the company's role in enhancing security through biometrics for access, making systems both more secure and convenient. With increasing concerns about data breaches and cyber threats, Bio-key addresses these issues with software and hardware solutions, helping employees and customers access authorized information more efficiently.

De Pasquale discussed the surge in cyber threats, emphasizing the accelerating frequency of data breaches. He also mentioned government mandates requiring companies to report breaches promptly and the necessity of multi-factor authentication for cyber insurance, a service Bio-key provides.

In Spain, a partnership has been established with a group that will collaborate with BIO-Key to implement AuthControl Sentry, one of the company's flagship solutions. AuthControl Sentry is highly regarded for its robust authentication capabilities, and it will play a pivotal role in safeguarding the login processes for both internal and external users of Tragsa.

Furthermore, Depasquale revealed that Haver & Boecker, a global leader in processing and packaging technology for bulk materials, has embraced Multifactor Authentication and Single Sign-On technology for its digital platforms. This implementation has been facilitated through P&W Netzwerk GmbH & Co. KG, leveraging BIO-Key Europe's AuthControl Sentry solution. This move is part of a strategic initiative aimed at enhancing efficiency and improving the overall user experience for Haver & Boecker's employees.

These contracts underscore the value and effectiveness of BIO-Key International's solutions in the realm of identity and access management, highlighting the company's ongoing commitment to providing cutting-edge cybersecurity solutions to its clients.

👍️0
wickw50 wickw50 5 months ago
Bridgetown, Barbados Credit Union Selects BIO-key’s PortalGuard to Enhance Access to Shared Workstations Including Biometrics


BRIDGETOWN, Barbados and HOLMDEL, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of passwordless, phoneless, and token-less Identity and Access Management (IAM) Multifactor Authentication (MFA) solutions, announced that the City of Bridgetown Co-operative Credit Union Ltd. (COB) has selected BIO-key’s PortalGuard platform with Identity-Bound Biometrics (IBB), to transform its secure login methodologies for staff access to critical systems and data. COB has multiple locations supporting more than 60,000 members in Barbados.

By implementing BIO-key’s PortalGuard platform with Identity-Bound Biometric authentication, COB ensures a more robust and reliable defense against unauthorized access to the credit union’s systems. Project requirements included meeting or exceeding cybersecurity insurance mandates and providing improved access workflows to support staff productivity. COB also desired a complete solution that could support multiple authentication factors including one-time passwords, biometrics or tokens.

These security and productivity requirements were especially important for shared workstation environments utilized by credit union tellers. PortalGuard’s centralized biometrics excel at providing instant support across a multitude of devices without requiring a hardware authentication device such as a phone or token. PortalGuard sets itself apart as a unified IAM platform, providing cutting-edge solutions to a range of use cases and business initiatives with flexibility to support a wide variety of authentication options and factors within an organization.

"BIO-key’s PortalGuard and IBB security solutions provide robust security and best-in-class support for shared workstations where other vendor solutions are limited and costly," said Mark Cochran, President of BIO-key’s PortalGuard division. "Credit Unions and other financial institutions are embracing BIO-key’s advanced biometric security measures because we can accommodate their unique authentication use cases with secure and cost-effective approaches that protect their systems and data. BIO-key is helping accelerate our customers’ ability to execute strategic security initiatives and meet their digital transformation and compliance goals."

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key
Facebook – Corporate:
LinkedIn – Corporate:
Twitter – Corporate:
Twitter – Investors:
StockTwits: https://www.facebook.com/BIOkeyInternational/
https://www.linkedin.com/company/bio-key-international
@BIOkeyIntl
@BIO_keyIR
BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
wickw50 wickw50 5 months ago
Certain Warrants of BIO-key International, Inc. are subject to a Lock-Up Agreement Ending on 30-JAN-2024.

January 29, 2024
Share
Certain Warrants of BIO-key International, Inc. are subject to a Lock-Up Agreement Ending on 30-JAN-2024. These Warrants will be under lockup for 91 days starting from 31-OCT-2023 to 30-JAN-2024.

Details:
Each of officers and directors and executive officers and any holders of five percent or more of the outstanding shares of common stock have agreed, subject to certain exceptions, not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any shares of common stock or other securities convertible into or exercisable or exchangeable for common stock for a period of 120 days after this offering is completed without the prior written consent of the placement agent.
👍️0
wickw50 wickw50 5 months ago
Up to 436,509 Shares of Common Stock


This prospectus relates to the resale, from time to time, by the selling stockholder identified in this prospectus under the caption “Selling Stockholder,” of up to 436,509 shares of our common stock, par value $0.0001 per share, issued and sold by us in a private placement transaction, consisting of 48,473 issued and outstanding shares of common stock, 126,131 shares issuable upon exercise of pre-funded warrants to purchase common stock, and 261,905 shares of common stock issuable upon exercise of common warrants. All share amounts in this prospectus have been adjusted to reflect the 1-for-18 reverse stock split that became effective on December 20, 2023.

All of the proceeds from the sale of the shares covered by this prospectus will be received by the selling stockholder. We will not receive any proceeds from the sale of these shares.
👍️0
wickw50 wickw50 6 months ago
Tragsa Group Enhances Cybersecurity with BIO-key’s Multi-Factor Authentication Solution
BIO-key International, Inc.
January 22, 2024 05:15 ET
MADRID, Spain and HOLMDEL, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced that Spain’s Grupo Tragsa (the Tragsa Group) has partnered with Factum España to implement BIO-key’s AuthControl Sentry solution. AuthControl Sentry, renowned for its comprehensive authentication capabilities, now plays a critical role in protecting the login processes of Tragsa’s internal and external users.

The implementation of AuthControl Sentry, complemented by a Virtual Private Network (VPN), enhances the overall security posture of Tragsa, ensuring encrypted and secure access across its vast network. The collaboration underscores Tragsa’s commitment to utilizing top-tier technology to maintain the highest standards of data security and operational integrity.

Alex Rocha, Managing Director of BIO-key Europe, remarked, “Tragsa’s decision to incorporate AuthControl Sentry into their security framework marks a significant stride in protecting their expansive network. The integration highlights Tragsa’s proactive approach to cybersecurity, ensuring both the safety and privacy of its data against ever evolving cyber threats. We are proud to support Tragsa in setting new standards for data protection and security. Our partnership with Factum España, a leader in cybersecurity implementation, not only showcases the robustness and adaptability of our solutions, but also demonstrates our collective commitment to advancing cybersecurity solutions for the challenges of today’s digital age.”

About Factum España (https://www.factum.es/)
Factum España is a specialist in cybersecurity solutions for enterprises ranging from large corporations to small and medium-sized companies. Its services range from advanced cybersecurity audits and consulting to the development of specialized products, solutions and managed services. Factum has a team of more than 140 specialists, allowing it to operate in a wide variety of sectors in Spain and internationally. Factum operates a Managed Detection & Response (MDR) center equipped with the latest innovations and currently provides cybersecurity solutions to more than 200 clients worldwide.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
Gizzer211 Gizzer211 6 months ago
Nice news
👍️0
wickw50 wickw50 6 months ago
Haver & Boecker Implements Single Sign-On (SSO) with Multifactor Authentication via P&W Netzwerk and BIO-key Europe to Secure and Streamline User Access


HOLMDEL, N.J. and OELDE, Germany, Jan. 17, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring Identity-Bound Biometric (IBB) authentication solutions, today announced that Haver & Boecker, a global leader in processing and packaging technology for bulk materials, has implemented Multifactor Authentication (MFA) and Single Sign-On (SSO) technology for its digital platforms via P&W Netzwerk GmbH & Co. KG, utilizing BIO-key Europe‘s AuthControl Sentry solution. The SSO integration is part of a strategic initiative to enhance efficiency and user experience for the Company’s employees.

Single Sign-on will allow access to multiple applications and services that, together with multifactor authentication, eliminate the complexity and lost time inherent in managing numerous passwords. This modernization reflects the customer’s commitment to identifying and adopting innovative technologies that improve workplace productivity.

Alex Rocha, Managing Director of BIO-key Europe, added, “Haver & Boecker’s decision to integrate an MFA and SSO solution that leverages the capabilities of AuthControl Sentry and the expertise of P&W Network, shows their forward-thinking approach to digital transformation. Such collaborations are crucial in an era where security and efficiency are paramount. BIO-key is proud to team with P&W Network to support innovative solutions that deliver operational and security improvements for forward-thinking industry leaders like Haver & Boecker.”

About P&W Network (www.puw-netzwerk.de)

For more than 20 years, P&W Network has been a reliable partner for complex IT infrastructures, network analysis and security. Their goal is to always offer the best solution to keep the end customer’s IT infrastructure secure and stable. Whether you need support with troubleshooting or simply want expert advice in the area of IT infrastructure – P&W Network is always a reliable and trusted IT partner.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
wickw50 wickw50 6 months ago
NJ-based Authentication Solutions Provider BIO-key to Review Growth Strategy and Progress at The Microcap Conf. in Atlantic City – Presentation Wed., Jan 31 at 10:50am ET


ATLANTIC CITY, N.J. and HOLMDEL, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of passwordless, phoneless, and token-less Identity and Access Management solutions leveraging proprietary biometric technology, will present and meet with investors at DealFlow Event’s Microcap Conference, Wed., January 31, 2024 at Caesars Atlantic City Hotel & Casino in New Jersey.

CEO Mike DePasquale will present on January 31st at 10:50am ET, on Track 5, and will be available for one-on-one meetings throughout the conference..

Registration Information:
Click here: https://themicrocapconference.com/tickets/ to register and attend the Microcap Conference. All investors are welcome to register and attend.

Mr. DePasquale commented, “Over the past two years we have built out an expanded base of solutions and a global footprint that is enabled by our channel alliance partners. Our business model has started to deliver the results we believe make BIO-key an exciting company and investment. The Microcap Conference provides a convenient, cost-effective opportunity for us to begin to reintroduce our company to investors.

Operating Highlights
“Our reported revenues grew 39% to $8.6M in the 12 months ended Sept 30, 2023, enabling a significant increase in gross profit. Importantly, we have recast our business into a largely recurring software as a service (SaaS) and services revenue model, which means that we start each year from an expanded base of contract activity, providing both stability and transparency for our growth and bottom-line performance.

“We have also made good progress in trimming overhead, contributing to reduced losses in recent periods, and we expect to benefit from these efforts as we move forward. From a valuation standpoint, we have approximately 1.937M common stock equivalents outstanding for a market cap of approximately $4M based on Friday’s closing price of $2.03. With an annual revenue run rate of nearly $9M and expected continued growth in revenues and improvement in our bottom-line performance, we are excited to present to prospective investors.”

Registration Information:
Click here: https://themicrocapconference.com/tickets/ to register and attend the Microcap Conference. All investors are welcome to register and attend.

About The Microcap Conference and DealFlow Events
Organized by DealFlow Events, the 3-day event at Caesars Atlantic City Hotel & Casino will feature company presentations from publicly-traded microcap businesses and qualified private companies across healthcare, technology, financial services, energy, and other high-growth sectors. Keynote presentations and panel discussions led by industry experts will provide insights into trading strategies, regulations, risk assessment and mitigation, tax issues, and other topics critical to the microcap community. Unlike many other microcap events, no invitation is required. The conference facilitates extensive networking through 1-on-1 investor meetings, interactive sessions as well as entertainment, including a poker tournament and an exclusive concert with Soul Asylum.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
Monksdream Monksdream 6 months ago
BKYI new 52 week low
👍️0
wickw50 wickw50 6 months ago
Crazy volume…. eom
👍️0
wickw50 wickw50 6 months ago
Fargo, ND and Junction City, KS Choose BIO-key PortalGuard For Secure Access via Biometric Authentication

Expect lower costs and superior user experience with biometrics


HOLMDEL, N.J., Jan. 11, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of passwordless, phoneless, and token-less Identity and Access Management (IAM) Multifactor Authentication (MFA) solutions, announced that Fargo, North Dakota and Junction City, Kansas are the latest municipalities to select BIO-key PortalGuard and its phoneless and tokenless Identity Bound Biometric (IBB) authentication options to add phish-resistance, enhance information security and streamline workflows while saving taxpayers money. A growing number of U.S. and global government entities have adopted BIO-key’s biometric authentication solutions to benefit from its unique combination of the highest-level of security, a superior end-user experience, greater flexibility, workflow efficiency, and competitive total cost of ownership. These new deployments reflect the cities’ commitment to safeguard the integrity and confidentiality of municipal data with state-of-the-art security solutions, while also fostering efficiency with a streamlined user-friendly experience.

BIO-key’s NIST- and independent lab-tested biometric security technology measures and compares unique biometric characteristics of users to verify and authenticate them, eliminating the need to carry phones or per-user tokens in order to access systems and get things done. Implementing biometric authentication in Fargo and Junction City ensures a more robust and reliable defense against unauthorized access to the cities’ systems. By relying on unique biological traits for authentication instead of passwords and other knowledge factors, municipalities can thwart common phishing threats and enhance the overall resilience and availability of their information systems.

Beyond a superior user experience and better resiliency to phishing and social engineering attacks, customers save money by choosing BIO-key PortalGuard’s biometric factors. BIO-key enables users to be their own authentication credential for sign in and account recovery, instead of requiring their employers to provision security tokens to each and every user or to require (and potentially, to reimburse) for personal phone use. The result is decreased reliance on costly physical identification factors such as hardware tokens, access cards, or users’ phones. Municipalities can re-allocate these long-term savings to optimize their budgets for the benefit of their community.

"The growing adoption of biometric authentication by U.S. municipalities reflects a continuing shift towards a more efficient, cost-effective, and user-friendly approach to securely authenticating to municipal digital services," said Mark Cochran, President of BIO-key’s PortalGuard division. "By embracing BIO-key’s advanced biometric security measures, forward-looking cities raise the ceiling on what their IAM systems can accommodate for users and use cases. We are glad to help Fargo and Junction City to enhance their security posture against cyber threats and contribute to the broader goal of safeguarding public trust in the digital age.”

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key
Facebook – Corporate:
LinkedIn – Corporate:
Twitter – Corporate:
Twitter – Investors:
StockTwits: https://www.facebook.com/BIOkeyInternational/
https://www.linkedin.com/company/bio-key-international
@BIOkeyIntl
@BIO_keyIR
BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800

👍️0
wickw50 wickw50 6 months ago
BIO-key PortalGuard Wins 2024 Business Intelligence Group’s BIG Innovation Award for its Authentication Software


HOLMDEL, N.J., Jan. 10, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less FIDO and Passkey authentication solutions through its unique Identity Bound Biometrics (IBB) capabilities, announced that its Access Management platform, PortalGuard® IDaaS was selected as the winner of a 2024 BIG Innovation Award presented by the Business Intelligence Group in the Software category.

BIO-key differentiates itself in the authentication market by more effectively addressing large scale enterprise and consumer passwordless and multi-factor (MFA) sign-in scenarios involving roving users and shared devices without imposing costly and cumbersome requirements that all users use and carry a phone, card or token in order to authenticate and access critical systems. For more than two decades, BIO-key has delivered more secure phoneless, tokenless and passwordless user experiences for some of the largest and most security-conscious entities in the world by offering secure, NIST-tested and fully privacy-law-compliant biometric authentication factors that identify the person, not what they are carrying. These unique what-you-are biometric factors allow every user to be their own credential, instead of mandating that they carry and use a personal phone, card or token to authenticate their identity along their digital journeys.

With cyber-insurers and regulatory bodies such as the SEC, FTC and FFIEC placing greater emphasis on deploying phish-resistant MFA and passwordless authentication, migrating all users off of vulnerable passwords and shared credentials is top of mind for organizations of all sizes and across all industries. BIO-key’s award-winning unified IAM platform, PortalGuard® IDaaS, along with IBB, allows enterprises to offer flexible options for authentication, including all of the traditional phone and token-based FIDO approaches, but adding the higher ceiling of a biometric-secured tokenless, phoneless option for everyday sign in and for self-service account recovery using biometric-secured identities in IBB.

“We are pleased to have been selected by Business Intelligence Group as a leader in the software category recognizing BIO-key for our advanced enterprise IAM solutions”, stated Mike DePasquale Chairman and CEO BIO-key.

“Innovation is driving our society,” said Maria Jimenez, chief nominations officer of the Business Intelligence Group. “We are thrilled to be honoring BIO-key International as they lead by example and improve the lives of many.”

Organizations from across the globe submitted their recent innovations for consideration in the BIG Innovation Awards. Nominations were then judged by a select group of business leaders and executives who volunteered their time and expertise to score submissions. After this rigorous selection process, BIO-key was named the winner of the BIG Innovation Award in the prestigious Software category.

About Business Intelligence Group
The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization’s proprietary and unique scoring system selectively measures performance across multiple business domains and then rewards those companies whose achievements stand above those of their peers.

Contact
Maria Jimenez
Chief Nominations Officer
Business Intelligence Group
jmaria@bintelligence.com
+1 (909) 529-2737

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key
Facebook – Corporate:
LinkedIn – Corporate:
Twitter – Corporate:
Twitter – Investors:
StockTwits:
https://www.facebook.com/BIOkeyInternational/
https://www.linkedin.com/company/bio-key-international
@BIOkeyIntl
@BIO_keyIR
BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
wickw50 wickw50 6 months ago
Denmark’s Ministry of Foreign Affairs Bolsters Network Security via IT2Trust and BIO-key®


COPENHAGEN, Denmark and HOLMDEL, N.J., Jan. 08, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced the Ministry of Foreign Affairs of Denmark is enhancing its digital security infrastructure for 4,500 users worldwide. The Ministry chose IT2Trust to implement a state-of-the-art Virtual Private Network secured by BIO-key Europe’s AuthControl Sentry authentication solution.

This deployment is part of the Ministry’s strategy to strengthen its digital capabilities in the face of evolving global cybersecurity challenges. The VPN solution provided by IT2Trust, a leading European digital security solutions provider, is pivotal in ensuring secure and efficient communication channels for the Ministry’s staff, both within Denmark and across embassies and consulates worldwide.

Alex Rocha, Managing Director of BIO-key Europe, remarked, “The Denmark’s Ministry of Foreign Affairs deployment of IT2Trust’s VPN and our AuthControl Sentry solution is a proactive effort to protect their systems and data from growing threats in an increasingly complex digital world. BIO-key Europe is proud to partner with IT2Trust to enhance the security and reliability of public sector digital infrastructure.

“The Ministry’s decision to work with IT2Trust reflects its commitment to adopting cutting-edge technology to protect sensitive information and maintain seamless global operations. The VPN implementation is a crucial aspect of the Ministry’s broader cybersecurity strategy seeking to ensure the highest standards of data protection and privacy.”

About IT2Trust (www.it2trust.com)
IT2Trust is the leading distributor of business critical information technology solutions in Nordic countries. IT2Trust earns this title by ensuring the right product matching for businesses and by offering competent advisory and guidance on all products from start to finish. It offers a wide range of vendor services enabling high quality-solutions. IT2Trust’s assistance covers everything from market- and competitor analyses and product positioning to marketing, technical support, and training at every level. With IT2Trust, you get a solution covering all needs, delivered by a serious and competent adviser and partner.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts

William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
Monksdream Monksdream 6 months ago
BKYI new 52 week high
👍️0
wickw50 wickw50 6 months ago
Hostile takeover? eom
👍️0
wickw50 wickw50 6 months ago
Over 1 million in volume traded… eom
👍️0
wickw50 wickw50 6 months ago
Wheeeeeee! eom
👍️0
Awl416 Awl416 6 months ago
What I tell ya. Fun to watch
👍️0
Awl416 Awl416 6 months ago
Not sure I’ve seen a ticker this manipulated in a while

Wash trades up ticking the bid

Spread had varied from .25 to a penny
👍️0
Yukoncole Yukoncole 6 months ago
Typically government, corruption is A Okay!
👍️0
wickw50 wickw50 6 months ago
Yokoncole, and, the SEC apparently, is ok with it…. eom
👍️0
Yukoncole Yukoncole 6 months ago
Yea, it’s also sickening!
👍️0
wickw50 wickw50 6 months ago
Yukon, Pretty amazing how Mickey D has managed to perpetuate a losing company for over 20 years….
👍️0
Monksdream Monksdream 6 months ago
BKYI new 52 week low
🍆 1 👎️ 1 🤡 1 🩳 1
Yukoncole Yukoncole 6 months ago
Won’t be long, as the past typically predict the future, and we will be back down to pre-split levels just like all the times before!!
👍️0
wickw50 wickw50 6 months ago
Portugal’s Judiciary Police Enhances Security Infrastructure via Securnet and BIO-key


HOLMDEL, N.J. and LISBON, Portugal, Jan. 02, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced the Judiciary Police of Portugal (Polícia Judiciária) has significantly enhanced its operational security by implementing a robust Virtual Private Network (VPN) secured by BIO-key Swivel Secure authentication technology AuthControl Sentry. The deployment was sourced through BIO-key’s strategic collaboration with Securnet.

The VPN, along with an advanced Access Control Device system provided by Securnet, significantly augments the security and efficiency of communications and data access for the Judiciary Police. The technologies support key infrastructure supporting the relentless fight against organized crime, terrorism, drug trafficking, corruption, as well as economic and financial crimes.

“The Judiciary Police’s commitment to advanced technological solutions is commendable,” said Alex Rocha, Managing Director of BIO-key Europe. “Our involvement in this project, through our partnership with Securnet, demonstrates the adaptability and strength of our security solutions in high-stakes environments. This collaboration is a prime example of how cutting-edge technology can empower law enforcement agencies to perform their critical duties more securely and effectively.”

“The implementation of these security solutions, facilitated by our collaboration with Securnet was pivotal in maintaining the integrity of communications. These technologies play a vital role in safeguarding information systems and operations, which are essential in the fight against sophisticated criminal networks.”

About Securnet (www.securnet.pt)
Founded in 2002 with the mission of putting organizations “Always online, Always Secure”, Securnet has evolved into a complete provider of IT infrastructure solutions and services. The excellence of Securnet solutions and services is widely recognized by customers and manufacturers as generators of value, innovation and competitiveness. Betting on transparent, trustworthy and long-term relationships, supported by an experienced, efficient, specialized and certified technical team, Securnet is a preferred supplier and technological partner of an increasing number of customers across a diverse range of sectors and industries.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

About the Judiciary Police (www.policiajudiciaria.pt)
The Polícia Judiciária (PJ; English: Judiciary Police) is the national criminal investigation police agency of Portugal, focused in fighting serious crimes, including homicides, kidnapping, organized crime, terrorism, illegal drug trade, corruption, cybercrime and financial crime. It is integrated into the Ministry of Justice, but operates under the supervision of the Public Ministry.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts

William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
👍️0
Awl416 Awl416 7 months ago
That mm ARCX continues to be a fraud
👍️0
wickw50 wickw50 7 months ago
Aw1416, Yes, I notice it’s just me here. Oh, and I don’t own any BKYI. It’s a long story…
👍️0
Awl416 Awl416 7 months ago
Notice it’s just you here. Nice day for you. Hope it goes higher for ya
👍️0

Your Recent History

Delayed Upgrade Clock